[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338057-105":59,"doc-detail-338057-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","targeting-cuproptosis-for-cancer-therapy-mechanistic-insights-and-clinical-perspectives","Targeting cuproptosis for cancer therapy - mechanistic insights and clinical perspectives","","Cuproptosis is a newly identified cell-death program driven by excessive intracellular copper accumulation. Mechanistically, copper triggers aggregation of dihydrolipoamide S-acetyltransferase, links to the mitochondrial tricarboxylic acid cycle, and causes loss of iron–sulfur cluster proteins, producing proteotoxic stress that culminates in cell death. The review connects cuproptosis to other cell-death modalities and surveys current agents and strategies, including copper ionophores, small compounds, and nanomedicine, as well as metabolic and gene-targeting approaches. It also evaluates therapeutic feasibility against chemotherapy and immunotherapy resistance and outlines future research directions.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-cuproptosis-for-cancer-therapy-mechanistic-insights-and-clinical-perspectives/338057/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-cuproptosis-for-cancer-therapy-mechanistic-insights-and-clinical-perspectives/338057.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is cuproptosis and what triggers it in cells?","Question",{"text":113,"@type":114},"Cuproptosis is a copper-induced form of cell death triggered by excessive intracellular copper accumulation. It involves copper-driven aggregation of DLAT, coordination with mitochondrial metabolism, and resulting proteotoxic stress.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does cuproptosis relate to mitochondrial and iron–sulfur processes?",{"text":118,"@type":114},"Cuproptosis is mechanistically linked to the mitochondrial tricarboxylic acid cycle and to loss of iron–sulfur cluster proteins. This contributes to proteotoxic stress that leads to cell death.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic strategies can induce or enhance cuproptosis in cancer treatment?",{"text":122,"@type":114},"Strategies include using copper ionophores, small compounds, and nanomedicine to induce cuproptosis. Approaches can also target cell metabolism or specific regulatory genes to sensitize tumors to cuproptosis.",{"name":124,"@type":111,"acceptedAnswer":125},"Why is targeting cuproptosis considered relevant for overcoming treatment resistance?",{"text":126,"@type":114},"The review discusses feasibility for addressing chemotherapy and immunotherapy resistance. It argues that cuproptosis targeting may open new avenues for developing tumor therapies with improved sensitivity.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},338057,1790194585,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":24,"preview_urls":151},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Zhang et al.  \nJournal of Hematology & Oncology (2024) 17:68 [https://doi.org/10.1186/s13045-024-01589-8](https://doi.org/10.1186/s13045-024-01589-8)  \nJournal of Hematology & Oncology  \n REVIEW Open Access  \nTargeting cuproptosis for cancer therapy:   mechanistic insights and clinical perspectives  \nChenliang Zhang1*†, Tingting Huang2† and Liping Li3  \nAbstract  \nCuproptosis is a newly identified form of cell death induced by excessive copper (Cu) accumulation within cells. Mechanistically, cuproptosis results from Cu-induced aggregation of dihydrolipoamide S-acetyltransferase, correlated with the mitochondrial tricarboxylic acid cycle and the loss of iron–sulfur cluster proteins, ultimately resulting in proteotoxic stress and triggering cell death. Recently, cuproptosis has garnered significant interest in tumor research due to its potential as a crucial therapeutic strategy against cancer. In this review, we summarized the cellular and molecular mechanisms of cuproptosis and its relationship with other types of cell death. Additionally, we reviewed the current drugs or strategies available to induce cuproptosis in tumor cells, including Cu ionophores, small compounds, and nanomedicine. Furthermore, we targeted cell metabolism and specific regulatory genes in cancer therapy to enhance tumor sensitivity to cuproptosis. Finally, we discussed the feasibility of targeting cuproptosis to overcome tumor chemotherapy and immunotherapy resistance and suggested future research directions. This study suggested that targeting cuproptosis could open new avenues for developing tumor therapy.  \nKeywords Copper, Cuproptosis, Cancer, Tumor therapy, Drug resistance, Tumor immunotherapy  \nIntroduction  \nCopper (Cu) is an essential trace metal element for normal physiological functions primarily obtained from dietary supplements. In biological systems, Cu exists predominantly in two oxidative states: divalent copper ions (Cu2+) and monovalent copper ions (Cu+). Cu+ is the principal oxidative form and plays a significant role  \n†Chenliang Zhang and Tingting Huang contributed equally to this work.  \n*Correspondence:  \nChenliang Zhang [zhangchenliang@wchscu.edu.cn](zhangchenliang@wchscu.edu.cn)  \n1 Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, People’s Republic of China  \n2 Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China  \n3 Department of Pharmacy, Chengdu Fifth People’s Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China  \nin physiological and pathological regulation within cells [1–3]. Disruptions in Cu homeostasis can induce disease onset; for instance, Cu overload may lead to Wilson’s disease [4], while Cu deficiency can cause Menkes disease [5]. Furthermore, previous studies have demonstrated that Cu could promote tumor cell proliferation, angiogenesis, and metastasis and reduces the efficacy of tumor treatments [6].  \nHowever, excess Cu in the cells can also cause cellular damage. Researchers observed that using Cu ionophores to elevate Cu levels within tumor cells could cause cell death [7, 8]. Although subsequent studies have extensively investigated the molecular mechanisms underlying Cu-induced cell death, such as the association of this typeof cell death with reactive oxygen species (ROS), apoptosis, and ferroptosis-related signaling pathways, the key mechanisms remain unclear. Tsvetkov et al. termed the Cu-induced cell death cuproptosis in 2022 based on their findings that this form of cell death depends on the aggregation of lipoylated dihydrolipoamide S-acetyltransferase (DLAT) and the reduction of iron–sulfur cluster (Fe–S)  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attri","cbCaieQ8Guo2QKXx","https://ap.wps.com/l/cbCaieQ8Guo2QKXx","pdf",5325374,42,"English","# Abstract\n# Introduction\n## Copper homeostasis and disease relevance\n## Copper-induced cell death and cuproptosis concept\n# Mechanisms and therapeutic targeting\n## Cellular and molecular pathways of cuproptosis\n## Inducing cuproptosis with drugs and nanomedicine\n## Sensitizing tumors via metabolism and regulatory genes\n# Clinical perspectives and resistance\n## Overcoming chemotherapy and immunotherapy resistance\n# Future directions","[{\"question\":\"What is cuproptosis and what triggers it in cells?\",\"answer\":\"Cuproptosis is a copper-induced form of cell death triggered by excessive intracellular copper accumulation. It involves copper-driven aggregation of DLAT, coordination with mitochondrial metabolism, and resulting proteotoxic stress.\"},{\"question\":\"How does cuproptosis relate to mitochondrial and iron–sulfur processes?\",\"answer\":\"Cuproptosis is mechanistically linked to the mitochondrial tricarboxylic acid cycle and to loss of iron–sulfur cluster proteins. This contributes to proteotoxic stress that leads to cell death.\"},{\"question\":\"What therapeutic strategies can induce or enhance cuproptosis in cancer treatment?\",\"answer\":\"Strategies include using copper ionophores, small compounds, and nanomedicine to induce cuproptosis. Approaches can also target cell metabolism or specific regulatory genes to sensitize tumors to cuproptosis.\"},{\"question\":\"Why is targeting cuproptosis considered relevant for overcoming treatment resistance?\",\"answer\":\"The review discusses feasibility for addressing chemotherapy and immunotherapy resistance. It argues that cuproptosis targeting may open new avenues for developing tumor therapies with improved sensitivity.\"}]","Targeting cuproptosis for cancer therapy - mechanistic insights and clinical perspectives | PDF",1790021768,106,[152,156,160,164,168],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a337428f99fbe877a0d3885901cd1053.webp",983,1305,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d113bb3194bb851e4df2a9dcb9bb17cb.webp",982,1304,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f707a9f86523af9fb11d38a5003afc1.webp",981,1303,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc8387f52e38fc78fe279ccc8915b5f5.webp",980,1301,{"page_no":24,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1e48f60d576150d9dae0ca778e3d05d.webp",979,1300]